Clarifying the role of TyG-VLR in CKM risk characterization: Reply to “Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome”

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2026-08-26
DOI
https://doi.org/10.1186/s12933-026-03337-3
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clarifying the role of TyG-VLR in CKM risk characterization: Reply to “Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome”

Qian Xu, Shuang-Ke Bai, Hao-Jie Han, Ao-Men Lu
Cardiovascular Diabetology
Parathyroid Disorders and Treatments
article

Clarifying the role of TyG-VLR in CKM risk characterization: Reply to “Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome”

Qian Xu, Shuang-Ke Bai, Hao-Jie Han, Ao-Men Lu
article en

Abstract

No abstract available for this paper.
Cardiovascular DiabetologyVol. 25(1)
Hebei North University (CN), Kailuan General Hospital (CN)
Openalex Percentile: Top 11%
Parathyroid Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clarifying the role of TyG-VLR in CKM risk characterization: Reply to “Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome” — Qian Xu, Shuang-Ke Bai, et al. · Cardiovascular Diabetology (2026) | TGRS Research Map | TGRS